Cargando…

Bone mineral density and explanatory factors in children and adults with juvenile dermatomyositis at long term follow-up; a cross sectional study

BACKGROUND: Juvenile dermatomyositis (JDM) is the most common idiopathic inflammatory myopathy in children and adolescents. Both the disease and its treatment with glucocorticoids may negatively impact bone formation. In this study we compare BMD in patients (children/adolescence and adults) with lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marstein, Henriette Schermacher, Godang, Kristin, Flatø, Berit, Sjaastad, Ivar, Bollerslev, Jens, Sanner, Helga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077908/ https://www.ncbi.nlm.nih.gov/pubmed/33902632 http://dx.doi.org/10.1186/s12969-021-00543-z

Ejemplares similares

Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study
por: Marstein, Henriette Schermacher, et al.
Publicado: (2023)

Adipose tissue distribution is associated with cardio-metabolic alterations in adult patients with juvenile-onset dermatomyositis
por: Marstein, Henriette S, et al.
Publicado: (2022)

Increased Levels of Eotaxin and MCP-1 in Juvenile Dermatomyositis Median 16.8 Years after Disease Onset; Associations with Disease Activity, Duration and Organ Damage
por: Sanner, Helga, et al.
Publicado: (2014)

Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis—a cross-sectional study
por: Witczak, Birgit Nomeland, et al.
Publicado: (2022)

A hospital based registry of juvenile idiopathic arthritis in Norway
por: Ingebrigtsen, Trude M, et al.
Publicado: (2014)

Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies
por: Schwartz, Thomas, et al.
Publicado: (2016)

Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients: A Randomized, Placebo-Controlled Trial
por: Jørgensen, Hanne Skou, et al.
Publicado: (2021)

Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study
por: Lien, Gunhild, et al.
Publicado: (2010)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

PReS-FINAL-2016: Bone mineral status in a long-term follow up of juvenile dermatomyositis patients
por: Kristensen, VA, et al.
Publicado: (2013)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

The Vasculopathy of Juvenile Dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2018)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
por: Pachman, Lauren M., et al.
Publicado: (2023)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

Juvenile dermatomyositis without skin lesions
por: Nilipour, Yalda, et al.
Publicado: (2015)

Pneumatosis Intestinalis Associated with Juvenile Dermatomyositis
por: Miyamae, Takako, et al.
Publicado: (2016)

Extensive ulcerative lesions in juvenile dermatomyositis
por: Bagri, Narendra Kumar, et al.
Publicado: (2020)

Clinical and autoantibody phenotypes of juvenile dermatomyositis
por: Boyarchuk, Oksana, et al.
Publicado: (2022)

B Cell Lymphocytosis in Juvenile Dermatomyositis
por: Costin, Christopher, et al.
Publicado: (2023)

Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis
por: Deakin, Claire T, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of Juvenile and Adult Dermatomyositis
por: Na, Sang-Jun, et al.
Publicado: (2009)

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
por: Opoka – Winiarska, Violetta, et al.
Publicado: (2011)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
por: Clara, Malagón, et al.
Publicado: (2011)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

PReS13-SPK-1030: Juvenile dermatomyositis
por: Quartier, P
Publicado: (2013)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

Consensus-based recommendations for the management of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2017)

Case of lipoatrophic diabetes induced by juvenile dermatomyositis
por: Baba, Yusuke, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e29stj6r1015dip8oslaa66jkc